Acknowledgements

AVAC would gratefully like to acknowledge our funders, without whom this project would not have been possible. The American Foundation for AIDS Research (AmFAR) and Broadway Cares/Equity Fights AIDS generously made the research, printing and distribution of this report possible, and the pace of the project was immeasurably quickened by a start-up grant from the Until There's a Cure Foundation. Special thanks are due Paul Corser of AmFAR and Tom Viola of Broadway Cares/Equity Fights AIDS.

We would also like to thank our affiliated organizations for their technical and administrative support, especially the gracious staff of AmFAR and the Center for AIDS Prevention Studies at UCSF. Thanks are due the San Francisco AIDS Foundation for their early assistance with fiscal administration.

Thanks also to our reviewers for their expertise and advice: John Moore of The Aaron Diamond AIDS Research Center; Pat Fast, Carole Heilman, and Jim McNamara of the Division of AIDS at the National Institute of Allergy and Infectious Diseases, NIH; Margaret Johnston of the International AIDS Vaccine Initiative; Wayne Koff of United Biomedical, Inc.; Steve Wakefield of The Night Ministries; and Mark Harrington and Bruce Shackman of the Treatment Action Group.

Spencer Cox of the Treatment Action Group and Beth Waters and Susan Hayes of Cooney-Waters, Inc. provided invaluable advice. The formatting and design of the report would not have been possible without Scott Shuchart and Brady Case.

And finally, we would like to thank the industry scientists and leaders we spoke with for their candid discussions of the inner workings of their companies and their field.

Table of contents